Literature DB >> 12897745

Endothelial protein C receptor-dependent inhibition of human eosinophil chemotaxis by protein C.

Clemens Feistritzer1, Daniel H Sturn, Nicole C Kaneider, Angela Djanani, Christian J Wiedermann.   

Abstract

BACKGROUND: Eosinophil infiltration is a characteristic feature of allergic inflammation. Allergic responses are associated with local activation of the coagulation pathway and accumulation of fibrin.
OBJECTIVE: We tested whether protein C and activated protein C (APC), which are endogenous anti-inflammatory coagulation inhibitors, affect eosinophil function.
METHODS: Eosinophils were from venous blood of healthy donors. Cell migration and apoptosis were studied by using micropore filter assays and fluorometry, respectively. Receptor expression was investigated by means of RT-PCR and SDS-PAGE of immunoprecipitated protein.
RESULTS: Protein C and APC had no significant chemotactic effects on eosinophils. Eosinophils pretreated with protein C or APC showed significantly reduced migration toward chemoattractants. No effect of either protein C preparation was seen in eosinophil apoptosis assays. The inhibiting effect on migration was reversed by an antibody against the endothelial protein C receptor (EPCR). Synthesis of EPCR by eosinophils is suggested by demonstration of receptor mRNA expression and detection of metabolically labeled receptor protein.
CONCLUSIONS: Data suggest that an EPCR is expressed by eosinophils whose activation with protein C or APC arrests directed migration. Protein C-affected eosinophil chemotaxis is a novel thrombin-independent component of the protein C pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12897745     DOI: 10.1067/mai.2003.1609

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  18 in total

1.  Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primates.

Authors:  András Gruber; Ulla M Marzec; Leslie Bush; Enrico Di Cera; José A Fernández; Michelle A Berny; Erik I Tucker; Owen J T McCarty; John H Griffin; Stephen R Hanson
Journal:  Blood       Date:  2007-01-16       Impact factor: 22.113

2.  Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1.

Authors:  Lea M Beaulieu; Frank C Church
Journal:  Exp Cell Res       Date:  2006-12-14       Impact factor: 3.905

Review 3.  The endothelial cell protein C receptor: cell surface conductor of cytoprotective coagulation factor signaling.

Authors:  Eimear M Gleeson; James S O'Donnell; Roger J S Preston
Journal:  Cell Mol Life Sci       Date:  2011-10-04       Impact factor: 9.261

4.  Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma.

Authors:  Iker Antón; Eva Molina; Diego Luis-Ravelo; Carolina Zandueta; Karmele Valencia; Cristina Ormazabal; Susana Martínez-Canarias; Naiara Perurena; María José Pajares; Jackeline Agorreta; Luis M Montuenga; Victor Segura; Ignacio I Wistuba; Javier De Las Rivas; José Hermida; Fernando Lecanda
Journal:  Am J Respir Crit Care Med       Date:  2012-03-29       Impact factor: 21.405

5.  Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in mice.

Authors:  Edward Kerschen; Irene Hernandez; Mark Zogg; Shuang Jia; Martin J Hessner; Jose A Fernandez; John H Griffin; Claudia S Huettner; Francis J Castellino; Hartmut Weiler
Journal:  J Clin Invest       Date:  2010-08-16       Impact factor: 14.808

Review 6.  The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications.

Authors:  Silvio Danese; Stefania Vetrano; Li Zhang; Victoria A Poplis; Francis J Castellino
Journal:  Blood       Date:  2009-12-17       Impact factor: 22.113

7.  Immunomodulation by alpha(1)-proteinase inhibitor: lack of chemotactic effects of recombinant human alpha(1)-proteinase inhibitor from yeast on human peripheral blood granulocytes.

Authors:  Birgit Mosheimer; Reinhard Alzner; Christian J Wiedermann
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-12-03       Impact factor: 4.291

8.  FoxA2 involvement in suppression of protein C, an outcome predictor in experimental sepsis.

Authors:  David T Berg; Bruce Gerlitz; Ganesh R Sharma; Mark A Richardson; Eddie J Stephens; Renee L Grubbs; Kimberly C Holmes; Kelly Fynboe; Dominick Montani; Martin S Cramer; Steven D Engle; Joseph A Jakubowski; Josef G Heuer; Brian W Grinnell
Journal:  Clin Vaccine Immunol       Date:  2006-03

9.  Recombinant human activated protein C inhibits integrin-mediated neutrophil migration.

Authors:  Gwendolyn F Elphick; Pranita P Sarangi; Young-Min Hyun; Joseph A Hollenbaugh; Alfred Ayala; Walter L Biffl; Hung-Li Chung; Alireza R Rezaie; James L McGrath; David J Topham; Jonathan S Reichner; Minsoo Kim
Journal:  Blood       Date:  2009-02-24       Impact factor: 22.113

Review 10.  Protective mechanisms of activated protein C in severe inflammatory disorders.

Authors:  Arne P Neyrinck; Kathleen D Liu; James P Howard; Michael A Matthay
Journal:  Br J Pharmacol       Date:  2009-05-14       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.